New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:06 EDTLGNDLigand price target raised to $91 from $78 at Summer Street
Summer Street raised its price target for Ligand shares to $91 following the company's Q4 results and 2014 outlook. It keeps a Buy rating on the stock.
News For LGND From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 11, 2015
11:31 EDTLGNDLigand price target raised to $127 from $116 at Roth Capital
Roth Capital raised its price target for Ligand Pharmaceuticals to $127 citing pipeline expansion following the company's Q1 results. Roth recommends "steady accumulation" of the stock and keeps a Buy rating on the name.
08:35 EDTLGNDLigand sees Q2 adjusted EPS 37c-40c, consensus 35c
Subscribe for More Information
08:34 EDTLGNDLigand affirms FY15 adjusted EPS view $2.14-$2.18, consensus $2.13
Subscribe for More Information
08:34 EDTLGNDLigand reports Q1 adjusted EPS 33c, consensus 27c
Reports Q1 revenue $14.6M, consensus $13.53M.
08:16 EDTLGNDLigand acquires rights to over 15 fully-funded development programs from Selexis
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use